Priceless GEMMs: genetically engineered mouse models for colorectal cancer drug development.

[1]  M. Pai,et al.  Consumption of high-fat diet induces tumor progression and epithelial-mesenchymal transition of colorectal cancer in a mouse xenograft model. , 2012, The Journal of nutritional biochemistry.

[2]  Steffen Jung,et al.  Utilization of Murine Colonoscopy for Orthotopic Implantation of Colorectal Cancer , 2011, PloS one.

[3]  Erin M. Coffee,et al.  The Dual PI3K/mTOR Inhibitor NVP-BEZ235 Induces Tumor Regression in a Genetically Engineered Mouse Model of PIK3CA Wild-Type Colorectal Cancer , 2011, PloS one.

[4]  Stefan Wirtz,et al.  Confocal laser endomicroscopy and narrow-band imaging-aided endoscopy for in vivo imaging of colitis and colon cancer in mice , 2011, Nature Protocols.

[5]  W. Zhou,et al.  Treatment of patient tumor-derived colon cancer xenografts by a TRAIL gene-armed oncolytic adenovirus , 2011, Cancer Gene Therapy.

[6]  J. Xie,et al.  Rh-I-UEA-1 Polymerized Liposomes Target and Image Adenomatous Polyps in the APCMin/+ Mouse Using Optical Colonography , 2011, Molecular imaging.

[7]  Thomas D. Wang,et al.  Targeted imaging of colorectal dysplasia in living mice with fluorescence microendoscopy , 2011, Biomedical optics express.

[8]  Ying Feng,et al.  In Vivo Fluorescence-Based Endoscopic Detection of Colon Dysplasia in the Mouse Using a Novel Peptide Probe , 2011, PloS one.

[9]  J. Heyer,et al.  KRAS Mouse Models: Modeling Cancer Harboring KRAS Mutations. , 2011, Genes & cancer.

[10]  B. Spencer‐Dene,et al.  FBXW7 influences murine intestinal homeostasis and cancer, targeting Notch, Jun, and DEK for degradation , 2011, The Journal of experimental medicine.

[11]  C. Xiong,et al.  In Vivo Small-Animal PET/CT of EphB4 Receptors Using 64Cu-Labeled Peptide , 2011, The Journal of Nuclear Medicine.

[12]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[13]  S. Cook,et al.  V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4a , 2010, EMBO molecular medicine.

[14]  Yu Sun,et al.  A superficial colon tumor model involving subcutaneous colon translocation and orthotopic transplantation of green fluorescent protein-expressing human colon tumor , 2010, Tumor Biology.

[15]  P. Snyder,et al.  Generation of a Transgenic Mouse for Colorectal Cancer Research with Intestinal Cre Expression Limited to the Large Intestine , 2010, Molecular Cancer Research.

[16]  P. Devilee,et al.  A new conditional Apc-mutant mouse model for colorectal cancer. , 2010, Carcinogenesis.

[17]  Euiheon Chung,et al.  In vivo wide-area cellular imaging by side-view endomicroscopy , 2010, Nature Methods.

[18]  R. Kucherlapati,et al.  An Msh2 conditional knockout mouse for studying intestinal cancer and testing anticancer agents. , 2010, Gastroenterology.

[19]  Umar Mahmood,et al.  Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment , 2010, Proceedings of the National Academy of Sciences.

[20]  T. Jacks,et al.  Complete deletion of Apc results in severe polyposis in mice , 2009, Oncogene.

[21]  David M Sabatini,et al.  mTOR and cancer: many loops in one pathway. , 2009, Current opinion in cell biology.

[22]  C. Baker,et al.  A metastatic colon cancer model using nonoperative transanal rectal injection , 2010, Surgical Endoscopy.

[23]  David Allard,et al.  Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer , 2009, Science.

[24]  Nina M. Muñoz,et al.  TGF-beta receptor inactivation and mutant Kras induce intestinal neoplasms in mice via a beta-catenin-independent pathway. , 2009, Gastroenterology.

[25]  Dongsheng Tu,et al.  K-ras mutations and benefit from cetuximab in advanced colorectal cancer. , 2008, The New England journal of medicine.

[26]  R. Kucherlapati,et al.  Loss of Rb1 in the gastrointestinal tract of Apc1638N mice promotes tumors of the cecum and proximal colon , 2008, Proceedings of the National Academy of Sciences.

[27]  H. Lane,et al.  Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in ApcΔ716 mice , 2008, Proceedings of the National Academy of Sciences.

[28]  A. Sweet-Cordero,et al.  Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon , 2008, Nature Genetics.

[29]  Kathleen R. Cho,et al.  Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation. , 2007, Cancer research.

[30]  H. Mori,et al.  Multistep carcinogenesis of the colon in ApcMin/+ mouse , 2007, Cancer science.

[31]  M. Neurath,et al.  High resolution colonoscopy in live mice , 2006, Nature Protocols.

[32]  B. Dutrillaux,et al.  Establishment of human colon cancer cell lines from fresh tumors versus xenografts: comparison of success rate and cell line features. , 2007, Cancer research.

[33]  Nina M. Muñoz,et al.  Transforming Growth Factor β Receptor Type II Inactivation Induces the Malignant Transformation of Intestinal Neoplasms Initiated by Apc Mutation , 2006 .

[34]  Ronald A. DePinho,et al.  Model organisms: The mighty mouse: genetically engineered mouse models in cancer drug development , 2006, Nature Reviews Drug Discovery.

[35]  Ji Luo,et al.  The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism , 2006, Nature Reviews Genetics.

[36]  Jennifer J. Lund,et al.  Adenomatous Polyposis Coli (APC) Is Required for Normal Development of Skin and Thymus , 2006, PLoS genetics.

[37]  H. Cooper,et al.  Generation of a unique strain of multiple intestinal neoplasia (Apc+/Min‐FCCC) mice with significantly increased numbers of colorectal adenomas , 2005, Molecular carcinogenesis.

[38]  H. Clevers,et al.  Cyclin D1 Is Not an Immediate Target of β-Catenin following Apc Loss in the Intestine* , 2005, Journal of Biological Chemistry.

[39]  Perry J Pickhardt,et al.  Microcomputed tomography colonography for polyp detection in an in vivo mouse tumor model. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[40]  M. Giovannini,et al.  Colorectal cancers in a new mouse model of familial adenomatous polyposis: influence of genetic and environmental modifiers , 2004, Laboratory Investigation.

[41]  Daniel Metzger,et al.  Tissue‐specific and inducible Cre‐mediated recombination in the gut epithelium , 2004, Genesis.

[42]  O. Sansom,et al.  Inducible Cre-mediated control of gene expression in the murine gastrointestinal tract: effect of loss of beta-catenin. , 2004, Gastroenterology.

[43]  Makoto M Taketo,et al.  Colonic polyposis caused by mTOR-mediated chromosomal instability in Apc+/Δ716 Cdx2+/− compound mutant mice , 2003, Nature Genetics.

[44]  L. Seymour,et al.  Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[45]  F. Pierre,et al.  Point: From animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[46]  K. Washington,et al.  Pathology of mouse models of intestinal cancer: consensus report and recommendations. , 2003, Gastroenterology.

[47]  L. Ellis,et al.  Effect of the vascular endothelial growth factor receptor‐2 antibody DC101 plus gemcitabine on growth, metastasis and angiogenesis of human pancreatic cancer growing orthotopically in nude mice , 2002, International journal of cancer.

[48]  Takuji Tanaka,et al.  Enhanced colon carcinogenesis induced by azoxymethane in min mice occurs via a mechanism independent of beta-catenin mutation. , 2002, Cancer letters.

[49]  B. Spiegelman,et al.  A Phase II Study of Troglitazone, an Activator of the PPARγ Receptor, in Patients with Chemotherapy‐Resistant Metastatic Colorectal Cancer , 2002 .

[50]  K. Forde,et al.  Colonoscopy in Mice , 2001, Surgical Endoscopy And Other Interventional Techniques.

[51]  J. Gordon,et al.  Inducible Gene Knockouts in the Small Intestinal and Colonic Epithelium* , 1999, The Journal of Biological Chemistry.

[52]  Samuel Singer,et al.  Differentiation and reversal of malignant changes in colon cancer through PPARγ , 1998, Nature Medicine.

[53]  S. Baba,et al.  Piroxicam and Acarbose as Chemopreventive Agents for Spontaneous Intestinal Adenomas in APC Gene 1309 Knockout Mice , 1998, Japanese journal of cancer research : Gann.

[54]  T. Noda,et al.  Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. , 1997, Science.

[55]  R. Kucherlapati,et al.  Loss of Apc and the entire chromosome 18 but absence of mutations at the Ras and Tp53 genes in intestinal tumors from Apc1638N, a mouse model for Apc-driven carcinogenesis. , 1997, Carcinogenesis.

[56]  A. Moser,et al.  Homozygosity for the Minallele of Apc results in disruption of mouse development prior to gastrulation , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.

[57]  M Oshima,et al.  Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[58]  R Fodde,et al.  A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[59]  K. Rajewsky,et al.  Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. , 1994, Science.

[60]  Bert Vogelstein,et al.  APC mutations occur early during colorectal tumorigenesis , 1992, Nature.

[61]  K. Kinzler,et al.  Erratum: Multiple Intestinal Neoplasia Caused By a Mutation in the Murine Homolog of the APC Gene , 1992, Science.

[62]  K. Kinzler,et al.  Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. , 1991, Science.

[63]  H. Pitot,et al.  A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. , 1990, Science.